Commonwealth Equity Services’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,757
Closed -$40.2K 4300
2025
Q4
$40.2K Sell
11,757
-3,453
-23% -$15.4K ﹤0.01% 4201
2025
Q3
$77K Sell
15,210
-21,217
-58% -$93.5K ﹤0.01% 4121
2025
Q2
$125K Buy
+36,427
New +$90.7K ﹤0.01% 4025
2023
Q4
Sell
-12,019
Closed -$55K 3900
2023
Q3
$55K Buy
12,019
+1,000
+9% +$6.08K ﹤0.01% 3645
2023
Q2
$71K Sell
11,019
-248
-2% -$1.69K ﹤0.01% 3616
2023
Q1
$84 Buy
11,267
+722
+7% +$6.56K ﹤0.01% 3521
2022
Q4
$106K Sell
10,545
-2,600
-20% -$30K ﹤0.01% 3408
2022
Q3
$130K Sell
13,145
-1,913
-13% -$21K ﹤0.01% 3312
2022
Q2
$160K Sell
15,058
-481
-3% -$4.07K ﹤0.01% 3271
2022
Q1
$151K Sell
15,539
-296
-2% -$2.8K ﹤0.01% 3398
2021
Q4
$226K Sell
15,835
-3,789
-19% -$57.5K ﹤0.01% 3194
2021
Q3
$393K Buy
+19,624
New +$347K ﹤0.01% 2668

Other funds holding ABCL